A unique collection of 1326 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;Effective tool for new anti-infective drugs high throughput screening and high content screening, containing sulfonamides, tetracyclines, aminoglycosides, and macrolide derivatives, etc.Bioactivity and safety confirmed by clinical research and trials;Detailed compound information with structure, target, activity, IC50 value, and biological activity description;Structurally diverse, medicinally active, and cell permeable;NMR and HPLC validated to ensure high purity and quality;